HILS logo

Hillstream BioPharma (HILS) Cash From Financing

Annual CFF

$13.06 M
+$12.17 M+1353.67%

December 31, 2022


Summary


Performance

HILS Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherHILScash flowmetrics:

Quarterly CFF

$1.85 M
+$1.32 M+252.66%

June 30, 2023


Summary


Performance

HILS Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherHILScash flowmetrics:

TTM CFF

$1.84 M
+$2.10 M+811.23%

June 30, 2023


Summary


Performance

HILS TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherHILScash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HILS Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1353.7%+839.5%-86.8%
3 y3 years+1744.2%--
5 y5 years+1744.2%--

HILS Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-93.1%-86.7%-127.6%-87.3%-114.1%
5 y5-yearat high-94.6%-86.7%-127.6%-87.3%-114.1%
alltimeall timeat high-94.6%-86.7%-127.6%-87.3%-114.1%

Hillstream BioPharma Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2023
-
$1.85 M(+252.7%)
$1.84 M(-811.2%)
Mar 2023
-
$523.40 K(-2426.2%)
-$258.30 K(-102.0%)
Dec 2022
$13.06 M(+1353.7%)
-$22.50 K(-95.6%)
$13.06 M(+0.1%)
Sep 2022
-
-$509.60 K(+104.2%)
$13.05 M(-6.1%)
Jun 2022
-
-$249.60 K(-101.8%)
$13.90 M(-3.6%)
Mar 2022
-
$13.85 M(<-9900.0%)
$14.42 M(+1504.7%)
DateAnnualQuarterlyTTM
Dec 2021
$898.70 K(-27.1%)
-$33.10 K(-110.0%)
$898.70 K(-3.6%)
Sep 2021
-
$332.60 K(+20.4%)
$931.80 K(+55.5%)
Jun 2021
-
$276.20 K(-14.5%)
$599.20 K(+85.5%)
Mar 2021
-
$323.00 K
$323.00 K
Dec 2020
$1.23 M(+73.9%)
-
-
Dec 2019
$708.40 K
-
-

FAQ

  • What is Hillstream BioPharma annual cash flow from financing activities?
  • What is the all time high annual CFF for Hillstream BioPharma?
  • What is Hillstream BioPharma annual CFF year-on-year change?
  • What is Hillstream BioPharma quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Hillstream BioPharma?
  • What is Hillstream BioPharma quarterly CFF year-on-year change?
  • What is Hillstream BioPharma TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Hillstream BioPharma?
  • What is Hillstream BioPharma TTM CFF year-on-year change?

What is Hillstream BioPharma annual cash flow from financing activities?

The current annual CFF of HILS is $13.06 M

What is the all time high annual CFF for Hillstream BioPharma?

Hillstream BioPharma all-time high annual cash flow from financing activities is $13.06 M

What is Hillstream BioPharma annual CFF year-on-year change?

Over the past year, HILS annual cash flow from financing activities has changed by +$12.17 M (+1353.67%)

What is Hillstream BioPharma quarterly cash flow from financing activities?

The current quarterly CFF of HILS is $1.85 M

What is the all time high quarterly CFF for Hillstream BioPharma?

Hillstream BioPharma all-time high quarterly cash flow from financing activities is $13.85 M

What is Hillstream BioPharma quarterly CFF year-on-year change?

Over the past year, HILS quarterly cash flow from financing activities has changed by +$2.10 M (+839.50%)

What is Hillstream BioPharma TTM cash flow from financing activities?

The current TTM CFF of HILS is $1.84 M

What is the all time high TTM CFF for Hillstream BioPharma?

Hillstream BioPharma all-time high TTM cash flow from financing activities is $14.42 M

What is Hillstream BioPharma TTM CFF year-on-year change?

Over the past year, HILS TTM cash flow from financing activities has changed by -$12.06 M (-86.78%)